OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
50
Results
Show all
Save search
Copy query
Show results for
Unknown
(50)
Publication Date
Release Date
2021
(12)
2025
(9)
2022
(7)
2023
(6)
2024
(3)
2011
(3)
2010
(3)
2020
(2)
2017
(2)
2016
(1)
2015
(1)
2014
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
Impact of Initial CSF Findings on Outcome Among Patients With National Cancer Institute Standard- and High-Risk B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.
Not available
S-EPMC5536164
|
biostudies-literature
Cite
Cross-National Trends in Early Sexual Initiation Among 15-Year-Old Adolescents, 2002-2022.
Not available
S-EPMC11932834
|
biostudies-literature
Cite
Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli-Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic Leukemia.
Not available
S-EPMC4715717
|
biostudies-literature
Cite
Dexamethasone in Hospitalized Patients with Covid-19.
Not available
S-EPMC7383595
|
biostudies-literature
Cite
Predictors of Outcomes in Patients With Mild Ischemic Stroke Symptoms: MaRISS.
Not available
S-EPMC9254134
|
biostudies-literature
Cite
Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis: The EVOLVED Randomized Clinical Trial.
Not available
S-EPMC11519785
|
biostudies-literature
Cite
Scaling and logic in the colour code on a superconducting quantum processor.
Not available
S-EPMC12443611
|
biostudies-literature
Cite
Socioeconomic status and incidence of sudden cardiac arrest.
Not available
S-EPMC3193117
|
biostudies-literature
Cite
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.
Not available
S-EPMC4486345
|
biostudies-literature
Cite
Outcome after reduced chemotherapy for intermediate-risk neuroblastoma.
Not available
S-EPMC2993160
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets